(Press-News.org)
Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their highly effective vaccines to fight the virus.
Since then, scientists have been fine-tuning this vaccine delivery system to make it more effective. A Yale research team has now developed a technology that improves both the power of mRNA vaccines and their effectiveness against a host of diseases.
The new technology offers the promise of expanding the reach of these vaccines, including for the prevention of other diseases, including cancer and autoimmune diseases.
The results of their study are published in Nature Biomedical Engineering.
Unlike traditional vaccines, which typically deliver an inactivated or weakened version of a virus to stimulate a person’s immune response, mRNA vaccines deliver genetic instructions that create a bit of a virus inside the individual’s cells. The cells then make the protein needed to create an immune response.
“Everyone is very familiar with mRNA vaccines from the pandemic,” said Sidi Chen, associate professor of genetics and neurosurgery at the Yale School of Medicine, who served as the study’s senior author. “But we wondered why the vaccine was working so well in COVID, but not so much in many other diseases that it was being tested on.”
The answer, it turns out, lies in the body’s response to antigens. Antigens are the substances that the immune system recognizes as foreign or possibly harmful, which then triggers an immune response.
But if the body doesn’t recognize an antigen, it can’t mount a good immune response. To be recognized by the body, antigens must attach to the surface of cells, where they are more easily detected. The problem, Chen explained, is that some antigens created by mRNA vaccine are unable to make it to surface. They get stuck deep within cells, evading the body’s immune response system.
To solve this challenge, they developed what they called a molecular vaccine platform (or MVP), which attaches a sort of “cell-GPS” module to the proteins that mRNA vaccines deliver to cells. This, in turn, guides the proteins to the cell surface where they stimulate greater antigen expression and can be seen by the immune system.
Researchers created these “GPS” modules from natural membrane proteins, such as signal peptides and transmembrane anchors that help antigens travel to the cell surface. (Signal peptides are short amino acid sequences that direct a protein to its correct location in a cell, and transmembrane anchors are segments within amino acids that secure proteins to cells, allowing them to move and to communicate.)
In a series of laboratory experiments, researchers tested the new platform on mpox (formerly known as monkeypox,) human papillomavirus (HPV, which is inked to cervical cancer,) and varicella-zoster virus (shingles.) In all cases, the platform produced stronger immune responses with dramatic improvements in antigen expression, antibody production, and T cell activation, Chen said.
The new platform could make future mRNA vaccines more reliable and effective against a host of different viruses, as well as other diseases.
“We’re taking an important step forward to allow us to broaden what the vaccines can be used for,” Chen said. “We’re trying to expand this type of technology to other diseases, such as cancer, HIV, and autoimmune conditions.”
Chen is also a member of the Systems Biology Institute at Yale’s West Campus and an affiliate of Yale Cancer Center, Yale Stem Cell Center, and Yale Center for Biomedical Data Science.
The study included 11 Yale-affiliated authors, with postdoctoral fellow Zhenhao Fang and Ph.D. candidate Valter Monteiro serving as first authors. In addition to Chen, senior authors were Carolina Lucas, assistant professor of immunobiology, and Daniel DiMaio, the Waldemar Von Zedtwitz Professor of Genetics, professor of molecular biophysics and biochemistry, and professor of therapeutic radiology.
END
Collaborative organizations, involving government agencies, nonprofit groups and other key stakeholders, are often created to address regional challenges such as preserving watersheds – but these organizations often fail to accomplish their stated goals. A new study suggests there is a specific administrative approach that improves the ability of these collaborative groups to deliver the services they were created to provide.
“These organizations tend to do a good job of planning, but then stumble when it comes to transitioning from the planning process to actually executing the projects and processes necessary to implement the plan,” says ...
CAMBRIDGE, MA -- Environmental scientists are increasingly using enormous artificial intelligence models to make predictions about changes in weather and climate, but a new study by MIT researchers shows that bigger models are not always better.
The team demonstrates that, in certain climate scenarios, much simpler, physics-based models can generate more accurate predictions than state-of-the-art deep-learning models.
Their analysis also reveals that a benchmarking technique commonly used to evaluate machine-learning techniques for climate predictions can be distorted by natural variations in the ...
LAWRENCE — Few people on Earth know as much about catfishes as University of Kansas researcher Gloria Arratia, who serves as editor and contributor to the just-published first volume of “Catfishes: A Highly Diversified Group” (CRC Press, 2025), a two-volume reference. While the first volume focuses on the fascinating anatomy of catfishes, the second will focus on their evolution and genetic relationships.
Arratia’s new work, co-written by Roberto Reis of Pontifícia Universidade Católica do Rio Grande do Sul in Brazil, reflects the latest understanding of the family tree of Siluriformes (the scientific name for catfishes), ...
Introducing Energy & Environment Nexus (E&E Nexus) – a pioneering, open-access platform dedicated to the critical intersection of energy systems and environmental challenges. We explicitly prioritize research exploring the dynamic interplay between energy and the environment, where innovation meets impact.
E&E Nexus Scope Spans Key:
????Interdisciplinary Science of Energy & Environment
????Renewable Energy & Low-Carbon Technologies
????Energy Materials & Nanotechnology
????Solid Waste Resource Utilization
????Pollution Control & ...
One of the great challenges faced by families coping with Alzheimer’s disease and other forms of dementia is learning how to communicate effectively with the person impacted by the disease while also upholding their personhood, or sense of personal value.
A new study from UConn researcher Amanda Cooper – published in time for World Alzheimer’s Month in September and World Alzheimer’s Day on Sept. 21 - offers concrete recommendations on what to do and what not to do to support personhood for a family member living with dementia.
“These ...
Paul Acosta, Assistant Research Professor, Atmospheric, Oceanic and Earth Sciences (AOES), College of Science, will receive funding for the project: “Collaborative Research: Mechanisms of moisture-driven ice growth: a warm Miocene data-model comparison.”
He and his collaborators will use state-of-the-art isotope-enabled general circulation and ice sheet models to test a suite of hypothesized mechanisms for precipitation-driven Antarctic ice growth during the Middle Miocene (17-15 Ma).
The proposed ...
A team from the Microbiology Department at the Icahn School of Medicine at Mount Sinai has discovered three powerful monoclonal antibodies from a person who had previously been infected with mpox (formerly known as monkeypox).
These antibodies, which target the viral protein A35, blocked viral spread in laboratory in vitro tests and, most importantly, protected rodents from severe disease and fully prevented death. The findings, published August 22 in Cell, also reveal that humans previously infected with mpox carry high levels of these protective antibodies in their blood, ...
Self-driving vehicles, drones, and robotic assistants are transforming industries including transportation, logistics, and health care. With new developments in hardware, AI, and machine learning, these autonomous agents can sense their surroundings with greater accuracy, understand complex environments, and engage in sophisticated reasoning.
But despite such advancements, deploying robots in dynamic, real-world settings—and getting them to do what we want—remains difficult.
“The overarching problem deals with robot capabilities,” says Cristian-Ioan Vasile, an assistant professor of mechanical engineering and mechanics in Lehigh University’s ...
ChatGPT and other generative AI models have achieved notable progress in natural language processing and generation, showing great potential in the medical field, such as automatically generating medical exam questions and answers, acting as personalized learning assistants, supporting course design, and aiding in medical imaging analysis. These models are also expected to be pivotal in training biosafety laboratory researchers by providing interactive learning experiences.
In this study, a dataset of 62 text-based and 8 image-based biosafety questions was collected ...
A special set of neurons directs mice’s attention to or away from their peers, depending on the situation. The Kobe University discovery has implications for finding causes for neuropsychiatric conditions such as autism spectrum disorder or schizophrenia.
Social interactions abound with decisions: How much time do we spend with a friend? Do we prioritize time with a friend who looks distressed? Like for all behavior, there are specialized clusters of neurons in the brain that are responsible for fine-tuning such complex behavior, and it is known that developmental defects in these areas are related ...
